达维塔保健(DVA)在10月30日美股夜盘交易中出现6.2%的大跌,引发了市场的广泛关注。这一暴跌的主要原因在于该公司第三季度财报中显示,高昂的患者护理成本正在严重侵蚀公司的利润水平。
作为一家领先的透析服务提供商,病人护理成本是达维塔保健最主要的运营支出。财报数据显示,第三季度该公司每次治疗的患者护理成本为257.46美元,同比上涨,导致利润率水平大幅下滑。
具体来看,达维塔保健第三季度营收32.6亿美元,符合分析师预期。但受护理成本上升影响,调整后每股收益2.59美元,低于分析师预期的2.73美元。更糟糕的是,预计第四季度护理成本居高不下的问题仍将持续,公司未来的利润率和盈利能力遭受质疑,因此引发了投资者的担忧情绪,导致股价暴跌。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.